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Abstract
In recent years, there has been an increasing interest in the mathematical and computational modeling of the
human immune system (HIS). Computational models of HIS dynamics may contribute to a better understanding of
the relationship between complex phenomena and immune response; in addition, computational models will
support the development of new drugs and therapies for different diseases. However, modeling the HIS is an
extremely difficult task that demands a huge amount of work to be performed by multidisciplinary teams. In this
study, our objective is to model the spatio-temporal dynamics of representative cells and molecules of the HIS
during an immune response after the injection of lipopolysaccharide (LPS) into a section of tissue. LPS constitutes
the cellular wall of Gram-negative bacteria, and it is a highly immunogenic molecule, which means that it has a
remarkable capacity to elicit strong immune responses. We present a descriptive, mechanistic and deterministic
model that is based on partial differential equations (PDE). Therefore, this model enables the understanding of how
the different complex phenomena interact with structures and elements during an immune response. In addition,
the model’s parameters reflect physiological features of the system, which makes the model appropriate for
general use.
Introduction
The human immune system (HIS) consists of a wide
and complex network of cells, tissues and organs. The
HIS plays a crucial role in defending the body against
disease. To achieve this goal, the HIS identifies and kills
a wide range of external pathogens such as viruses and
bacteria as well as the body’s own abnormally behaving
cells. The HIS is also responsible for removing dead
cells and regenerating some of the body’s structures [1].
A complete understanding of the HIS is therefore
essential. However, its complexity and the intense inter-
actions among several components on various different
levels make this task extremely complex [2,3]. However,
we may better understand some properties of the HIS
by applying a computational model, which allows
researchers to test a large number of hypotheses in a
short period of time [2,3]. In the future, we can envision
a computer program that will simulate the entire HIS,
allowing scientists to develop and test new drugs against
various diseases virtually, thus reducing the number of
animals used in experiments.
In this study, our work aims to implement and simu-
late a mathematical model of the HIS. Due to the com-
plexity of this task, our focus is to reproduce the spatio-
temporal dynamics of an immune response to the injec-
tion of lipopolysaccharides (LPS) into a small section of
tissue. To reproduce these dynamics, we introduce a
mathematical model composed of a system of partial
differential equations (PDEs) that extends our previous
model [2] and defines the dynamics of representative
cells and molecules of the HIS during the immune
response to LPS. The model presented is descriptive,
mechanistic and deterministic; therefore, it enables the
understanding of how different complex phenomena,
structures and elements interact during an immune
response. In addition, the model’s parameters reflect the
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physiological features of the system, making the model
appropriate for general use.
The remainder of the paper is organized as follows.
First, the necessary biological background is presented.
Next, related works are briefly discussed. This exposi-
tion is followed by a description of both the mathemati-
cal model proposed in this work and its computational
implementation. Then simulation results obtained from
the proposed model are discussed, and finally, our con-
clusions and plans for future work are presented.
Biological background
“Human body surfaces are protected by epithelia, which
provide a physical barrier between internal and external
environments. Epithelia make up the skin and lining of
the tubular structures of the body (i.e., the gastrointest-
inal, respiratory and genitourinary tracts), and they form
an effective barrier against the external environment. At
the same time, epithelia can be crossed or settled by
pathogens, causing infections. After crossing the epithe-
lium, the pathogens encounter cells and molecules of
the innate immune system, which immediately develop
a response” [4].
The body’s initial response to an acute biological
stress, such as a bacterial infection, is an acute inflam-
matory response [4]. The strategy of the HIS is to keep
some resident macrophages on guard in tissues to look
for any signal of infection. When they find such a signal,
the macrophages alert neutrophils (also known as poly-
morphonuclear neutrophils (PMNs)) that their help is
required. Because of this communication, the coopera-
tion between macrophages and neutrophils is essential
to mount an effective defense against disease. Without
macrophages to herd neutrophils toward the location of
infection, the latter would circulate indefinitely in the
blood vessels, impairing the control of systemic infec-
tions [1].
The inflammation of an infectious tissue has many ben-
efits for the control of the infection. In addition to
recruiting cells and molecules of innate immunity from
blood vessels to the location of the infected tissue,
inflammation increases the lymph flux, which contains
microorganisms and cells that carry antigens to neigh-
boring lymphoid tissues; there, these cells will present
the antigens to the lymphocytes and initiate the adaptive
response. Once the adaptive response has been activated,
the inflammation also shuttles the effector cells of the
adaptive immune system to the location of infection [4].
A component of the cellular wall of Gram-negative bac-
teria, such as LPS, can trigger an inflammatory response
through the interaction with receptors on the surface of
some cells [1]. For example, the macrophages that reside
in tissue recognize a bacterium through the binding of
TLR4 (Toll-like receptor 4) with LPS. When receptors on
the surface of macrophages bind to LPS, the macrophage
starts to phagocytose, internally weakening the bacterium
and secreting proteins known as cytokines and chemo-
kines, as well as other molecules.
In many inflammatory conditions, neutrophils domi-
nate the initial influx of leukocytes into the inflamed tis-
sue. The first wave of extravasated neutrophils is soon
replaced by a second wave of monocytes [1]. A study
presented initial proofs of the existence of this sequence
of events [5]. In that study, neutrophils dominated the
leukocyte extravasation three hours after the beginning
of the inflammation, and some time later, the extrava-
sated cells were predominantly monocytes [5].
The resolution of the inflammatory response is a com-
plex process that includes the production of anti-inflam-
matory mediators and the apoptosis (or programmed
death) of effector cells of the HIS, such as neutrophils
[6]. Anti-inflammatory cytokines form a set of immu-
noregulatory molecules that control the inflammatory
response. These cytokines work together with specific
inhibitors and cytokines’ soluble receptors to regulate
the immune response [6]. A previous work [6] demon-
strated the participation of cytokines in inflammatory
states. Primary anti-inflammatory cytokines include the
antagonist receptor of IL-1 (Interleukin 1) in addition to
IL-4, IL-6, IL-10, IL-11 and IL-13 [6]. Specifically, IL-10
is a strong inhibitor of many pro-inflammatory cyto-
kines [7], including IL-8 and TNF-a (tumor necrosis
factor a), which are produced both by monocytes [8]
and by neutrophils [9,10].
Apoptotic cells maintain membrane integrity for a
small period of time and therefore need to be quickly
removed to prevent a secondary necrosis and the conse-
quent release of cytotoxic molecules, which cause
inflammation and tissue damage [11]. As a consequence
of the phagocytosis of apoptotic cells by macrophages or
dendritic cells, these phagocytic cells produce anti-
inflammatory cytokines. For example, macrophages
secrete TGF-b (transforming growth factor b), which
prevents the release of pro-inflammatory cytokines
induced by LPS [12]. Additionally, the binding of apop-
totic cells to macrophage receptor CD36 (cluster of
differentiation 36) inhibits the production of pro-inflam-
matory cytokines such as TNF-a, IL-1b and IL-12; this
binding also increases the secretion of TGF-b and IL-10
[13].
Related work
This section presents and discusses other models found in
the literature to model the innate HIS. Essentially, two dis-
tinct approaches are used: ordinary differential equations
(ODEs) and partial differential equations (PDEs).
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Models based on ODEs
The authors of [14] presented a model of inflammation
that is based on ODEs and considers three types of
cells/molecules: the pathogen and two inflammatory
mediators. This model was able to reproduce some
experimental results depending on the values used for
initial conditions and parameters. The authors described
the results of the sensitivity analysis, which suggests
some therapeutic strategies. Their work was then
extended [15] to investigate the influence of time on an
anti-inflammatory response. The mathematical model
presented in [15] consists of a system of ODEs with
four equations that model: a) the pathogen; b) the active
phagocytes; c) tissue damage; and d) anti-inflammatory
mediators. The source term of the phagocytes, in other
words, a term that models the entry of new phagocytes
into the infected tissue, is a function that depends on a)
the concentration of phagocytes; b) the concentration of
pathogens; and c) tissue damage. This term models the
different interactions that phagocytes can undergo dur-
ing an immune response, whether the interactions are
direct or mediated by cytokines. In the interaction
mediated by cytokines, they consider only the implicit
presence of cytokines. For example, in an immune
response, the interaction of phagocytes with tissue is
mediated by pro-inflammatory cytokines produced by
infected epithelial tissue cells, and this relationship is
modeled directly in the source term of the phagocytes.
This representation contrasts with the model proposed
in the current work, where cytokines and all their inter-
actions are explicitly represented.
A new adaptation of the first model [14] was proposed
to simulate many scenarios involving repeated doses of
endotoxin [16]. This work applied results obtained
through experiments using mice to guide in silico
experiments seeking to reproduce these results qualita-
tively. The mathematical model represents the key
aspects of an acute inflammatory response, specifically
when repeated doses of endotoxin are administered.
This model replaces the pathogen equation proposed in
the authors’ previous work [15] with an equation incor-
porating the endotoxin. In their simulations, they
observed that the timing and magnitude of endotoxin
doses, as well as the dynamics between pro- and anti-
inflammatory mediators, are key to distinguishing
between potentiation and tolerance phenomena [16].
The authors also argued that their model, although sim-
plified, nevertheless incorporates sufficiently complex
dynamics to qualitatively reproduce a set of experimen-
tal results associated with different endotoxin adminis-
trations in mice.
One final work [17] developed a more complete sys-
tem of ODEs that models acute inflammation. This
model includes macrophages, neutrophils, dendritic
cells, TH1 cells, blood pressure, tissue trauma, effector
elements such as iNOS, NO−2 and NO
−
3 , pro-inflamma-
tory and anti-inflammatory cytokines, and coagulation
factors. In this model, as well as our own (described in
detail in the next section), neutrophils and macrophages
are directly activated by LPS. Moreover, activation also
occurs indirectly by way of various stimuli consistently
elicited after a trauma or hemorrhage. However, the
model proposed by [17] does not explicitly include
initial events of inflammation such as mast cell degranu-
lation and complement activation, although these factors
were incorporated implicitly into cytokine and endo-
toxin dynamics. The model also includes anti-inflamma-
tory cytokines such as IL-10 and TGF b, in addition to
soluble receptors for pro-inflammatory cytokines. The
authors argued that their model proved useful in simu-
lating the inflammatory response induced in mice by
endotoxin, trauma and surgery or surgical bleeding, as it
can predict levels of TNF, IL-10, IL-6 and reactive pro-
ducts of NO (NO−2 and NO
−
3 ) to some extent.
Models based on PDEs
The model proposed by Su et al [18] uses a system of
PDEs to represent the spatial dynamics of the innate
and adaptive immune systems. It considers the simplest
form of antigens, the molecular constituents of pathogen
patterns, taking into account all the basic factors of an
immune response: antigens, cells of the immune system,
cytokines and chemokines. This model captures the fol-
lowing stages of immune response: recognition, initia-
tion, effector response and resolution of infection or
change to a new steady state. Accordingly, it can repro-
duce important phenomena such as a) the temporal
order of cell arrival at the site of infection; b) antigen
presentation by dendritic cells, macrophages and the
involvement of regulatory T cells (Treg) in the resolu-
tion of the immune response; c) the production of pro-
inflammatory and anti-inflammatory cytokines; and d)
chemotaxis. This model has formed the basis for the
development of our work.
Mathematical model
The complete modeling of the HIS demands that a huge
amount of work be performed by a large multidisciplin-
ary team. In this work, we focus on a specific task: the
development of a mathematical model of the innate
immune response to the injection of LPS in a section of
tissue, as well as such a model’s computational imple-
mentation. One motivation for developing a model of
the innate immune system is the fact that few such
models are available in the literature; the majority of
available models solely focus on the adaptive immune
system. Another reason in favor of modeling the innate
immune system is that many diseases result from the
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malfunction of the innate immune system; for these dis-
eases, our proposed model could contribute to the defi-
nition of therapeutic strategies. In addition, a better
comprehension of the inner workings of the separate
parts composing the innate immune system is funda-
mental to a better understanding of immune response
as a whole, as the innate immune system is responsible
for both initiating the immune response and triggering
the adaptive immune system.
Our objective is to develop a parameterized mathemati-
cal model of the human innate immune system that
simulates the immune response occurring in a generic
tissue. To achieve this goal, we first build a model of the
immune response to LPS. We have chosen to use LPS
because it is the major component of the outer mem-
brane of Gram-negative bacteria, acting as an endotoxin
substance that elicits strong immune responses; thus, it
represents a vast number of inflammatory diseases. How-
ever, our proposed model is generic in the sense that it
can be easily adapted to specific pathogens and distinct
types of tissue through the adjustment of its parameters.
The mathematical model simulates the temporal and
spatial behavior of lipopolysaccharide (LPS), macro-
phages, neutrophils (N), apoptotic neutrophils (ND), pro-
inflammatory cytokines (CH), anti-inflammatory cytokine
(AC) and protein granules (G). Macrophages are present
in two states of readiness: resting (RM) and hyperacti-
vated (AM). The different subsets of protein granules
[19] released by neutrophils during their extravasation
from blood vessels to the tissues are represented by a
unique variable. Additionally, we must stress that the
equations modeling pro- and anti-inflammatory cyto-
kines are generic in the sense that they model the role of
distinct cytokines taking part in the inflammatory pro-
cess. Equation parameters can be adjusted to model the
role of a specific pro- or anti-inflammatory cytokine.
Our model extends the model proposed by Su et al [18]
by considering a macroscopic or homogenized view of a
tissue. In [18], the exchange between the vascular system
(arterioles and vessels) and tissue was assumed to occur
only at the boundaries of the domain, via Dirichlet
boundary conditions. Our model allows each point of the
tissue to be irrigated by arterioles and vessels, so that
cells in the blood stream can enter into the tissue at any
point. This is equivalent to a two-domain model, in
which one domain represents the concentration of
immune cells in the vascular system (in our case, neutro-
phils, N max(x, t), and macrophages, Mmax(x, t)) and the
other domain represents the different cells and molecules
present in the tissue (our model considers lipopolysac-
charide (LPS), neutrophils (N), apoptotic neutrophils
(ND), pro-inflammatory cytokines (CH), anti-inflamma-
tory cytokines (AC), protein granules (G), resting (RM)
and hyperactivated (AM) macrophages). Communication
between the two different domains is possible and is
modeled by permeabilities that vary in space and time
and may depend on the concentration of different cells
and molecules (in our model, the endothelium perme-
ability of neutrophils depends on the concentration of
CH, whereas the permeability to macrophages depends
on the concentration of both CH and G). Figure 1 pre-
sents our two-domain macroscopic model.
The main characteristics of the proposed model are:
• Macrophages and neutrophils cooperate to mount
a more effective and intense response against the
LPS;
• The endothelium’s permeability may vary with
time and space and also depends on the local con-
centration of pro-inflammatory cytokine and protein
granules, as depicted by Figure 1;
• Active macrophages regulate immune responses
through the production of anti-inflammatory cyto-
kines and the phagocytosis of apoptotic neutrophils;
• Anti-inflammatory cytokines perform a key role in
the control of the inflammatory response, avoiding a
state of persistent inflammation after the complete
elimination of LPS.
Figure 2 depicts the relationships among all of the mod-
el’s components. Neutrophils, resting macrophages and
active macrophages phagocytose the LPS. The neutrophils
then undergo apoptosis, which may or may not be induced
by the phagocytosis process. In this different state, apopto-
tic neutrophils cannot perform phagocytosis or produce
pro-inflammatory cytokines; as a result, apoptotic neutro-
phils are eliminated from the body after being phagocy-
tosed by active macrophages. The number of apoptotic
neutrophils in the serum is an indirect indication of the
probability that the immune response will cause tissue
damage, because apoptotic neutrophils will die after a per-
iod of time, releasing cytotoxic granules and degradation
enzymes in the medium that can cause tissue damage.
Neutrophils produce pro-inflammatory cytokines, such as
TNF-a and IL-8, as well as protein granules, which allow
the direct activation and adhesion of monocytes in the
endothelium of blood vessels, facilitating monocytes’ extra-
vasation into the tissue. The resting macrophages become
active when they recognize the LPS. The pro-inflammatory
cytokines produced by neutrophils and active macrophages
increase the permeability of the blood vessels; conse-
quently, more neutrophils and monocytes are recruited to
the tissue. In addition, the pro-inflammatory cytokines act
as a chemoattractant substance to the resting macro-
phages, active macrophages and neutrophils. The produc-
tion of the pro-inflammatory cytokine is blocked when an
active macrophage or neutrophil comes in contact with an
anti-inflammatory cytokine. Macrophage activation is also
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blocked by the action of an anti-inflammatory cytokine,
which is produced by active macrophages and by resting
macrophages that are in contact with apoptotic
neutrophils.
Below, we provide the equations derived from the







∂ t = −μLPSLPS − RMactivation − (λN|LPSN + λAM|LPSAM).LPS +DLPSLPS
LPS(x, 0) = LPS0,
∂LPS(.,t)
∂n |∂ = 0
(1)
In this equation, μLPSLPS denotes the decay of LPS,
where μLPS is the rate of decay, RMactivation denotes the
activation of resting macrophages, where jRM|LPS is the
rate of activation. This activation occurs when resting
macrophages recognize the LPS, after which macro-
phages phagocytose the LPS. lN|LPS.N denotes the pha-
gocytosis of LPS by neutrophils, where lN|LPS is the rate
of this phagocytosis. lAM|LPS.AM denotes the phagocyto-
sis of LPS by active macrophages, where lAM|LPS is the
rate of this phagocytosis. DLPSΔLPS denotes LPS diffu-
sion, whereas DLPS represents the diffusion coefficient.
Figure 3 presents a schematic representation of the dif-
fusion process implemented by the diffusion operator,
DLPSΔLPS, and illustrates the diffusion of cells through
the tissue. Diffusion is defined as the spread of particles
from regions of higher concentration to regions of lower
concentration.
The differential equation corresponding to the resting
macrophage (RM) is given in Equation 2.
⎧⎪⎪⎪⎪⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎪⎪⎪⎪⎩
RMP = (PmaxRM − PminRM ). CH(CH+keqch) + PminRM
RMQ = (QmaxRM − QminRM). G(G+keq g) +QminRM
sourceRM = (RMP + RMQ).(Mmax − (RM + AM))
∂RM
∂ t = −μRMRM − RMactivation +DRMRM + sourceRM − ∇.(χRMRM∇CH)
RM(x, 0) = RM0,
∂RM(.,t)
∂n |∂ = 0
(2)
RMP and RMQ denote the increase in endothelium
permeability and its effects on monocyte extravasation.
The permeability of blood vessel endothelium is mod-
eled by a Hill equation [20], which also has been used
to model drug dose-response relationships [21]. The
idea is to model the increase in the permeability of the
endothelium in accordance with the number of pro-
inflammatory cytokines deposited on the endothelium.
Figure 4 illustrates the effect of increasing blood vessel
permeability. We can see that the space between two
neighboring endothelial cells increases, allowing more
cells to extravasate to the tissue. The dynamic perme-
ability depends on the cytokine concentration.
Figure 1 Two-domain model. Schematic representation of the two-domain model. The extravasation of neutrophils (or macrophages) from
blood to tissue depends on local permeability, P(x, t), and on the difference between local concentrations of neutrophils in the two domains,
Nmax(x, t) - N(x, t). The permeability of the endothelium, which separates the two domains, varies with regard to time and space and depends on
the local presence of pro-inflammatory cytokines and protein granules.
Pigozzo et al. BMC Bioinformatics 2013, 14(Suppl 6):S7
http://www.biomedcentral.com/1471-2105/14/S6/S7
Page 5 of 20
The calculation of RMP involves the following para-
meters: a) PmaxRM , the maximum endothelium permeability
induced by the pro-inflammatory cytokine; b) PminRM, the
minimum endothelium permeability induced by the pro-
inflammatory cytokine; and c) keqch, the number of
pro-inflammatory cytokines that exert 50% of the maxi-
mum effect on permeability.
RMQ denotes the increase in endothelium permeability
induced by protein granules, and its calculation is simi-
lar to that of RMP, except for the parameters involved:
QminRM, Q
min
RM and keq_g. sourceRM denotes the source term
of macrophages, which is related to the number of
monocytes that will enter into the tissue from the blood
vessels. This number depends on the endothelium per-
meability RMP + RMQ and on the number of monocytes
appearing in the blood (Mmax).
μRM RM denotes resting macrophage apoptosis, where
μRM is the apoptosis rate. RMactivation, as explained
above, models the activation of resting macrophages and
denotes the number of resting macrophages that are
becoming active. The term DRMΔRM denotes the resting
macrophage diffusion, where DRM is the diffusion coeffi-
cient. ∇.(cRMRM∇CH) denotes the resting macrophage
chemotaxis, where cRM is the chemotaxis rate.
Figure 5 provides a schematic representation of the
chemotaxis process implemented by the chemotaxis
operator, ∇.(cRMRM∇CH). Chemotaxis is the phenom-
enon by which cells direct their own movements
according to certain chemicals present in their
environment.
The differential equation corresponding to the active
macrophage (AM) is given in Equation 3.
{
∂AM
∂ t = −μAMAM + RMactivation +DAMAM − ∇.(χAMAM∇CH)
AM(x, 0) = AM0,
∂AM(.,t)
∂n |∂ = 0
(3)
Above, μAMAM, DAMΔAM, and ∇.(cAMAM∇CH)
denote the active macrophage apoptosis, diffusion, and
chemotaxis, respectively, whereas μAM, DAM, and cAM
are the apoptosis rate, diffusion coefficient, and chemo-
taxis rate, respectively.
The differential equation for the pro-inflammatory




∂ t = −μCHCH + ((βCH|N.N.LPS + βCH|AM.AM.LPS).(1 − CHchInf ))/(1 + θAC.AC)+
+DCHCH
CH(x, 0) = CH0,
∂CH(.,t)
∂n |∂ = 0
(4)
In this equation, μCHCH denotes the pro-inflammatory
cytokine decay, where μCH is the decay rate. bCH|N.N
Figure 2 Model’s relations. Relations among the components of the model.
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Figure 3 Diffusion process. Schematic representation of the diffusion process.
Figure 4 Permeability. Representation of the differences between fixed and dynamic permeabilities.
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denotes the pro-inflammatory cytokine production by
the neutrophils, where bCH|N is the production rate.
bCH|AM.AM denotes the pro-inflammatory cytokine pro-
duction by active macrophages, where bCH|AM is the
production rate. The saturation of cytokine production
by active macrophages is calculated by the equation
(1 − CHchInf ), where chInf is an estimate of the maximum
quantity of pro-inflammatory cytokine supported by the
tissue. The production of pro-inflammatory cytokine
decreases when anti-inflammatory cytokine acts on the
producing cells. This influence of anti-inflammatory
cytokine is denoted by the expression 1/(1 + θAC.AC).
DCHΔCH models pro-inflammatory cytokine diffusion,
where DCH is the diffusion coefficient.




PN = (PmaxN − PminN ). CHCH+Keqch + PminN
sourceN = PN.(Nmax − N)
∂N
∂ t = −μNN − λLPS|NLPS.N +DNN + sourceN − ∇.(χNN∇CH)
N(x, 0) = N0,
∂N(.,t)
∂n |∂ = 0
(5)
In this equation, PN denotes the increase in endothe-
lium permeability and its effects on neutrophil extrava-
sation. In the top equation, PmaxN is the maximum
endothelium permeability induced by pro-inflammatory
cytokines, PminN is the minimum endothelium perme-
ability induced by pro-inflammatory cytokines and
keqch is the number of pro-inflammatory cytokines
that exert 50% of the maximum effect on endothelium
permeability.
Here, μNN denotes neutrophil apoptosis, where μN is
the rate of apoptosis. lLPS|N LPS.N denotes the neutro-
phil apoptosis induced by phagocytosis, where lLPS|N
represents the rate of this induced apoptosis. The term
DNΔN denotes neutrophil diffusion, where DN is the dif-
fusion coefficient. sourceN represents the source term of
neutrophil, i.e., the number of neutrophils entering the
tissue from the blood vessels. This number depends on
the endothelium permeability (PN) and on the number
of neutrophils in the blood (Nmax). The term ∇.
(cNN∇CH) denotes the chemotaxis process of the neu-
trophils, where cN represents the chemotaxis rate.
Figure 5 Chemotaxis process. Schematic representation of chemotaxis.
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The differential equation corresponding to the apopto-
tic neutrophil (ND) is given in Equation 6.
{
∂ND
∂ t = μNN + λLPS|NLPS.N − λND|AMND.AM +DNDND
ND(x, 0) = ND0,
∂ND(.,t)
∂n |∂ = 0
(6)
Here, note that μNN and lLPS|NLPS.N were defined
previously, whereas lND|AMND.AM denotes the phago-
cytosis of the apoptotic neutrophil carried out by active
macrophages, and lND|AM is the rate of this phagocyto-
sis. DNDΔND models the apoptotic neutrophil diffusion,
where DND is the diffusion coefficient.
The differential equation for protein granules (G) is
given in Equation 7.{
∂G
∂ t = −μGG + αG|N.sourceN.(1 − GgInf ) +DGG
G(x, 0) = G0,
∂G(.,t)
∂n |∂ = 0
(7)
μGG models the decay of the granules, where μG is the
decay rate. aG|N.sourceN denotes the production of pro-
tein granules by neutrophils extravasating from the
blood into inflamed tissue, where aG|N is a dimension-
less constant. The saturation of protein granule produc-
tion is calculated by the expression (1 − GgInf ), where
gInf is the maximum number of protein granules.
DGΔG models protein granule diffusion, where DG is
the diffusion coefficient.
The differential equation for the anti-inflammatory
cytokine (AC) is given in Equation 8.
{
∂AC
∂ t = −μACAC + (βRM|ND.RM.ND + αAC|AM.AM).(1− ACacInf ) +DACAC
AC(x, 0) = AC0,
∂AC(.,t)
∂n |∂ = 0
(8)
In this equation, μACAC denotes the anti-inflammatory
cytokine decay, where μAC represents the decay rate.
bRM|ND.RM.ND denotes the anti-inflammatory cytokine
production by the resting macrophages in the presence
of apoptotic neutrophils, where bRM|ND is the rate of
this production. aAC|AM.AM denotes the anti-inflamma-
tory cytokine production by active macrophages, where
this production has rate aAC|AM and saturation
(1 − ACacInf ), where acInf is the maximum number of
anti-inflammatory cytokines in the tissue. DACΔAC
models the anti-inflammatory cytokine diffusion, where
DAC is the diffusion coefficient.
Implementation
The numerical method that we have applied to our math-
ematical model is presented in our previous work [2].
We executed some convergence tests to test the imple-
mentation of our numerical method. In short, we assumed
that the correct solution derived from the results of a very
refined mesh, where the refinement was in terms of time
(dt = 10-6day) and space (deltaX = 0.1mm). To show con-
vergence with respect to time, we selected two new values
for dt, dt1 = 4.0 × 10-6day and dt2 = 8.0 × 10-6day. We
applied the L2-norm to compute the errors when using
dt1 and dt2 for our refined mesh. We observed that the
error when using dt2 was 2.3 times greater than the error
obtained with dt1. Therefore, as theoretically predicted,
our numerical scheme is first-order accurate with respect
to time. We then conducted the same analysis for conver-
gence with respect to space, choosing two new values of
deltaX, dx1 = 0.4mm and dx2 = 0.8mm. The L2-norm
error when using dx2 was 2.03 times greater than the
error obtained with dx1. Once again, the values obtained
were as expected, as we were using a first-order discretiza-
tion (upwind) in space. These results gave us confidence
that our numerical solver had been correctly implemented.
Numerical experiments
The model’s initial conditions and parameters are given
in Tables 1 and 2, respectively. In our simulations, we
assumed a one-dimensional domain of 5 mm length and
a simulation time of 5 days. In fact, this one-dimensional
model is a simplification of a 3D block model in that we
have assumed that the lengths associated with y and z are
much smaller than the length associated with x.
In this paper, we obtained parameter values for humans
whenever they were available. We chose values for the
initial concentrations of LPS according to the work of the
authors in [22]. In their experiments, E. coli cells were
inoculated intradermally (108) into normal and neutrope-
nic rabbits. They reported that all bacteria and inflamma-
tory cells were contained in this 1.5 cm diameter biopsy
and restricted to its 0.2 cm thick layer of dermal collagen.
Thus, the volume of dermis in which the E. coli cells were
contained was approximately 0.35 cm3 [23]. This finding
suggested us a value of LPS0 = 100.0 × 10
4 cells/mm3 .
In Table 2, parameters marked with * were adjusted to
qualitatively reproduce the results obtained in several
studies of the immune response to LPS. In the case of
LPS, we adjust the equation parameters to obtain an
exponential decrease, as shown in [24]. The results of the
concentration of pro-inflammatory cytokines over time
are qualitatively similar to those obtained in some
Table 1 Initial Conditions
Parameter Value Unit
LPS0 100: 0<x < 1 10
4cells/mm3
LPS0 0: 1 ≤ x < 5 10
4cells/mm3
RM0 1: 0 <x < 5 10
4cells/mm3
AM0 0: 0 <x < 5 10
4cells/mm3
CH0 0: 0 <x < 5 10
4cells/mm3
N0 0: 0 <x < 5 10
4cells/mm3
ND0 0: 0 <x < 5 10
4cells/mm3
G0 0: 0 <x < 5 10
4cells/mm3
AC0 0: 0 <x < 5 10
4cells/mm3
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experimental works [25-27]. The time course for the
anti-inflammatory cytokine is qualitatively similar to the
results in [25]. An important feature present in our
model is the inhibition of the production of pro-inflam-
matory cytokines by neutrophils through the action of
anti-inflammatory cytokines [10]. The protein granule
model behavior is based on existing work [28]. The
parameters marked with ** were based on the values
given in the references but were adjusted due to the use
of distinct units (for example, from L to mm3) or to fit in
a 5 mm tissue.
In Figure 6, we initially inject LPS only into a small
part of the tissue. As time progresses, we can see two
important phenomena occurring: the diffusion of LPS
through the tissue and the decrease of LPS mainly due
to the action of neutrophils and macrophages.
In the case of neutrophils (Figure 7), we can witness
an increase in neutrophil population mainly in regions
of tissue having higher levels of LPS. This increase hap-
pens because of an increase in endothelium permeability
in addition to the chemotaxis process attracting neutro-
phils to regions possessing more pro-inflammatory cyto-
kines. When the amount of LPS is low, the neutrophil
population stops growing and starts to decrease because
fewer neutrophils are entering into the tissue.
In Figure 8, we observe an increase of pro-inflamma-
tory cytokines until 6 hours, when a large number of
neutrophils are present in the tissue. Afterwards, the
number of pro-inflammatory cytokines decreases, mainly
due to the presence of a large number of active macro-
phages. Consequently, the anti-inflammatory cytokine
population increases. The decrease of CH has many
important consequences: fewer neutrophils and mono-
cytes are migrating to the inflamed tissue, and fewer
macrophages are becoming active, as can be observed in
Figure 9. This figure shows that the active macrophage
population grows until 12 hours and then starts to
decrease because, as explained before, anti-inflammatory
cytokines inhibit the activation of resting macrophages.
Comparison of different scenarios
To show the importance of some cells, molecules and pro-
cesses in the dynamics of the innate immune response, we
performed a set of simulations under different scenarios.
Each simulation begins with a simple scenario in which we
assume that only macrophages participate in the immune
response to LPS (Case 1). We then consider progressively
more complex scenarios. In each subsequent scenario, a
new set of equations and terms are added to the previous
one until the complete scenario is obtained (Case 5).
A description of each case is given below:
• Case 1: only macrophages participate in the
immune response. Resting tissue-resident macro-
phages are responsible for the initial response to LPS.
• Case 2: considers a) the production of pro-inflam-
matory cytokines by active macrophages; and b) all
effects of pro-inflammatory cytokines, such as the
increase in permeability and chemotaxis.
• Case 3: incorporates neutrophils into the model,
which participate in the immune response as a
Table 2 Parameters
Parameter Value Unit Reference
jRM|LPS 0.1 1/(cells/mm3).day [18]**
θAC 1 1/(cells/mm
3) estimated*
μLPS 0.005 1/day [18]
lN|LPS 0.55 1/(cells/mm3).day [18]
lAM|LPS 0.8 1/(cells/mm3).day [18]
DLPS 2000 μm
2/day estimated*
PmaxRM 0.1 1/day estimated*
PminRM 0.01 1/day estimated*
QmaxRM 0.5 1/day estimated*
QminRM 0 1/day estimated*
keqch 1 cells/mm3 estimated*
keq_g 1 cells/mm3 estimated*
Mmax 6 cells/mm3 estimated*










μCH 7 1/day [18]**
bCH|N 1 1/(cells/mm3).day [34]
bCH|AM 0.8 1/(cells/mm3).day [34]
chInf 3.6 cells/mm3 [8]**
DCH 9216 μm
2/day [18,29]
PmaxN 11.4 1/day [35]**
PminN 0.0001 1/day estimated*
keqch 1 cells/mm3 estimated*
Nmax 8 cells/mm3 estimated*
μN 3.43 1/day [36]





lND|AM 2.6 1/(cells/mm3).day [18]
DND 0.144 μm
2/day [18]**
μG 5 1/day estimated*
aG|N 0.6 dimensionless estimated*
gInf 3.1 cells/mm3 estimated*
DG 9216 μm
2/day estimated*
μAC 4 1/day estimated*
bRM|ND 1.5 1/(cells/mm3).day estimated*
aAC|AM 1.5 dimensionless estimated*
acInf 3.6 cells/mm3 [8]**
DAC 9216 μm
2/day [29]
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Figure 6 LPS concentration in space. Temporal evolution of the spatial distribution of LPS.
Figure 7 Neutrophil concentration in space. Temporal evolution of the spatial distribution of neutrophil.
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Figure 8 Pro-inflammatory cytokine concentration in space. Temporal evolution of the spatial distribution of pro-inflammatory cytokine.
Figure 9 Active macrophage concentration in space. Temporal evolution of the spatial distribution of active macrophage.
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major phagocytic leukocyte. They are also responsi-
ble for producing pro-inflammatory cytokines.
• Case 4: incorporates protein granules into the
model, which are produced by neutrophils and con-
tribute to an increase in the endothelium’s perme-
ability, allowing more monocytes to enter into the
tissues and differentiate in resting macrophages.
• Case 5: incorporates anti-inflammatory cytokines
into the model. In this case, anti-inflammatory cyto-
kines block the production of pro-inflammatory
cytokines by the neutrophils and active macro-
phages. In addition, anti-inflammatory cytokines
block the activation of resting macrophages.
Figure 10 depicts the temporal evolution of the total
amount of LPS in the tissue. Observe that the introduc-
tion of pro-inflammatory cytokines in Case 2 causes a
small decrease in the amount of LPS when compared to
Case 1. This decrease has occurred because our model
considers the pro-inflammatory cytokine influence on
monocyte migration to be almost negligible.
In Case 3, the decrease in LPS has been accelerated
due to the presence of neutrophils migrating into the
tissue in huge quantities. The number of neutrophils in
the tissue is enough to control the infection.
In Case 4, observe that the extravasation of a second
wave of monocytes (a consequence of the presence of
protein granules produced by the neutrophils) has no
impact on the potentiation of the immune response
because the LPS has been almost completely eliminated.
Note that the LPS decrease is smaller in case 5 than in
cases 3 and 4. This fact is a consequence of the pre-
sence of anti-inflammatory cytokines in the model,
which causes a decrease in the number of neutrophils
and monocytes extravasating to the tissue.
Figure 11 depicts the temporal evolution of the popu-
lation of resting macrophages and demonstrates that the
introduction of pro-inflammatory cytokines, neutrophils
and protein granules (Cases 2, 3 and 4) contributes to
an increase in endothelium permeability, which in turn
allows the entry of more monocytes. As a consequence,
the number of resting macrophages increases, an
increase compounded between Cases 4 and 5 because
anti-inflammatory cytokines are blocking the activation
of resting macrophages.
Figure 12 presents the temporal evolution of the active
macrophage population. Observe that an increase in this
population occurs from Case 1 to Case 2, which is due
to the production of pro-inflammatory cytokines by
active macrophages, which have also increased perme-
ability and chemotaxis. In Case 3, the introduction of
neutrophils contributes to a faster elimination of LPS,
and as a result, less LPS is available to activate resting
macrophages. When protein granules are included in
the model (Case 4), we can observe an increase in the
quantity of active macrophages. This population increase
Figure 10 Temporal evolution LPS. Temporal evolution of the total quantity of LPS.
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Figure 11 Temporal evolution resting macrophage. Temporal evolution of the resting macrophage population.
Figure 12 Temporal evolution active macrophage. Temporal evolution of the active macrophage population.
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has occurred because protein granules allow the direct
activation and adhesion of monocytes in the endothe-
lium of blood vessels, thus facilitating the monocytes’
extravasation to the tissues. Finally, a significant reduc-
tion in the total amount of active macrophages occurs
in Case 5 due to the action of anti-inflammatory cyto-
kines, which block the activation of resting macro-
phages. In addition, anti-inflammatory cytokines block
the production of pro-inflammatory cytokines, causing a
decrease in endothelium permeability and consequently
in the number of monocytes extravasating to the tissue.
Observe the significant increase in the number of pro-
inflammatory cytokines in Figure 13 between Cases 2
and 3. This increase is a direct consequence of the
incorporation of neutrophils into the model, as neutro-
phils produce a huge amount of pro-inflammatory cyto-
kines. No change occurs between Cases 3 and 4 because
the entry of more monocytes into the tissue occurs dur-
ing termination of the immune response, when the LPS
available to activate the monocytes is small. In Case 5,
the reduction in production of pro-inflammatory cyto-
kines due to the action of anti-inflammatory cytokines is
responsible for the decrease in the total quantity of pro-
inflammatory cytokines.
Figure 14 depicts the temporal evolution of the neutro-
phil population, whose increase is similar in Cases 3 and
4 due to the fact previously stated: the entry of more
monocytes into the tissue occurs during termination of
the immune response. In Case 5, the number of neutro-
phils into the infected tissue is smaller than in Case 4
because fewer pro-inflammatory cytokines are present in
the tissue, which results in a reduction in the number of
neutrophils migrating into the infected tissue.
Figure 15 illustrates a small decrease in the number of
apoptotic neutrophils between Cases 3 and 4. This
reduction is a consequence of the presence of more
active macrophages in Case 4 than in Case 3. In Case 5,
the presence of fewer active macrophages in the tissue
leads to a reduction in the number of apoptotic neutro-
phils that are phagocytosed.
Figure 16 shows an increase in the number of protein
granules between Case 4 and Case 5. In Case 4, the
number of neutrophils migrating to the infected tissue is
larger, causing an increase in protein granule production
as well.
Finally, Figure 17 depicts the temporal evolution of the
anti-inflammatory cytokine population. Observe that the
number of anti-inflammatory cytokines increases after
the termination of the infection (as shown in Figure 10).
Conclusions and future works
In this work, we have presented a computational model
for the dynamics of representative types of cells and
molecules of the HIS during an innate response to the
injection of LPS into a small section of tissue. To achieve
this objective, we have proposed a mathematical model
Figure 13 Temporal evolution pro-inflammatory cytokine. Temporal evolution of the pro-inflammatory cytokine population.
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that incorporates the main interactions occurring
between LPS and some cells and molecules of the innate
immune system. The model proposes a macroscopic or
homogenized view of tissue composed of two different
domains: one domain represents the concentration of
immune cells in the vascular system (in our case, neutro-
phils, Nmax(x, t), and macrophages, Mmax(x, t)), whereas the
other domain represents the different cells and molecules
Figure 14 Temporal evolution neutrophil. Temporal evolution of the neutrophil population.
Figure 15 Temporal evolution apoptotic neutrophil. Temporal evolution of the apoptotic neutrophil population.
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Figure 16 Temporal evolution protein granule. Temporal evolution of the protein granule population.
Figure 17 Temporal evolution anti-inflammatory cytokine. Temporal evolution of the anti-inflammatory cytokine population.
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present in the tissue (our model considers lipopolysac-
charide (LPS), neutrophils (N), apoptotic neutrophils
(ND), pro-inflammatory cytokines (CH), anti-inflamma-
tory cytokines (AC), proteins granules (G), resting (RM)
and hyperactivated (AM) macrophages). Communication
between the two different domains is possible and is
modeled by an endothelium permeability that varies in
space and time and may depend also on the concentra-
tion of different cells and molecules (in our model, the
endothelium’s permeability to neutrophils depends on
the concentration of CH, whereas its permeability to
macrophages depends on CH and G).
The model proposed in this work has been able to
reproduce several features present in immune responses,
such as:
• the order of arrival of cells at the site of infection,
as shown in [39];
• the coordination of macrophages and neutrophils
to mount a more effective and intense response to
LPS;
• the endothelium’s dynamic permeability, which
may depend on local concentrations of pro-inflam-
matory cytokines and protein granules;
• the important role of protein granules throughout
the process of monocyte extravasation;
• the regulation of immune response by macro-
phages through the production of anti-inflammatory
cytokines and the phagocytosis of apoptotic
neutrophils;
• the crucial role of anti-inflammatory cytokines in
the control of the inflammatory response, thus
avoiding a state of persistent inflammation after the
complete elimination of LPS.
In future work, we plan to implement a more complete
mathematical model that includes new cells (such as nat-
ural killer and dendritic cells), molecules and other pro-
cesses involved in the immune response. The model could
be extended by any of the following methods: a) including
the interaction between endothelial cells, LPS and some
cytokines such as IL-1b and TNF-a [40]; b) incorporating
the fact that high amounts of LPS also induce an increase
in endothelium permeability [40]; c) considering the pro-
cess of macrophage desensitization, in which high levels of
LPS inhibit the production of TNF-a by macrophages
[41]; d) taking into account that the TNF-a produced by
macrophages induces the production of even more TNF-a
[1]; and e) considering that the TNF-a has proapoptotic
and antiapoptotic effects on macrophages and neutrophils.
In low concentrations, TNF-a delays the apoptosis of
macrophages and neutrophils and induces the production
of pro-inflammatory cytokines, whereas in high concentra-
tions, it induces apoptosis [41].
An important final step is the validation of our proposed
model using experimental data. Of particular interest is
the spatio-temporal modeling of microabscess formation,
a very important research topic. For instance, [42-45] pre-
sents animal studies detailing the formation of liver
abscess and microabscess by different types of infections.
Epidermal microabscess formation by neutrophils was also
evaluated in [46-48] and [22]. Infection of the heart by
bacteria (bacterial myocarditis [49]) or by viruses (viral
myocarditis [50]) is also correlated with microabscess for-
mation by neutrophils. The interaction between tumor
cells and inflammatory cells plays an important role in
cancer initiation and progression and was investigated in
[51] for the case of tumor-infiltrating neutrophils in pan-
creatic neoplasia, where the pattern of microabscess for-
mation by neutrophils was reported once again. We
acknowledge that this distinct pattern of formation can
only be numerically reproduced and studied by models
that capture the spatio-temporal dynamics of the HIS.
Therefore, in the near future, we plan to extend our PDE
model and adjust its parameters in the hopes of reprodu-
cing some of these experimental findings.
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